Finance

Lists
Outlook: 50.0% bullish·0.0% bearish
Go to analysis
WST:NYSE
West Pharmaceutical Services Inc
၃၆၆.၀၀ US$
+၀.၇၅%
(+၂.၇၃) 1D
၃၆၆.၀၀ US$
၀.၀၀% (၀.၀၀)
After hours
Closed: အောက် ၉, GMT-၄ ၁၆:၀၂:၂၀  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for WST...
Open
၃၆၃.၃၁ US$
High
၃၇၀.၂၀ US$
Low
၃၆၂.၁၈ US$
Mkt. cap
ဋေ ၂.၅၈ ထ
Avg. vol.
၅.၇၇ သိန်း
Volume
၄.၈၀ သိန်း
Dividend
၀.၂၄%
Quarterly dividend
၀.၂၂ US$
Ex-dividend date
၂၀၂၆ ဇူ ၂၉
P/E ratio
၄၆.၇၉
52-wk high
၃၈၆.၀၀ US$
52-wk low
၂၂၃.၈၃ US$
EPS
၇.၈၂ US$
Beta
၁.၁၃
Shares outstanding
၇.၀၄ ကုဋေ
No. of employees
၁ သောင်း
Open
၃၆၃.၃၁ US$
High
၃၇၀.၂၀ US$
Low
၃၆၂.၁၈ US$
Mkt. cap
ဋေ ၂.၅၈ ထ
Avg. vol.
၅.၇၇ သိန်း
Volume
၄.၈၀ သိန်း
Dividend
၀.၂၄%
Quarterly dividend
၀.၂၂ US$
Ex-dividend date
၂၀၂၆ ဇူ ၂၉
P/E ratio
၄၆.၇၉
52-wk high
၃၈၆.၀၀ US$
52-wk low
၂၂၃.၈၃ US$
EPS
၇.၈၂ US$
Beta
၁.၁၃
Shares outstanding
၇.၀၄ ကုဋေ
No. of employees
၁ သောင်း
News stories
From web sources and news partners
Zacks
Zacks
·
ပြီးခဲ့သည့် ၇ နာရီ
ANGO Q1 Earnings Beat Estimates on Med Tech Growth, Revenues Up Y/Y
Zacks
Zacks
·
ပြီးခဲ့သည့် ၇ နာရီ
Reasons to Hold Veeva Systems Stock in Your Portfolio for Now
Zacks
Zacks
·
ပြီးခဲ့သည့် ၁ ရက်
Smith+Nephew Launches CARTIHEAL Implant Across Key European Markets
Zacks
Zacks
·
ပြီးခဲ့သည့် ၁ ရက်
Here's Why You Should Retain WAT Stock in Your Portfolio for Now
Profile
West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. Founded in 1923 by Herman O. West and J.R. Wike of Philadelphia, the company is headquartered in Exton, Pennsylvania. In its early years of development, West produced rubber components for packaging injectable drugs, providing a sterile environment for the producers of penicillin and insulin. Wikipedia
About West Pharmaceutical Services Inc
CEOEric M. Green
Employees၁.၀၈ သောင်း
Founded၁၉၂၃
HeadquartersWest Whiteland Township, ပင်ဆယ်ဗေးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Analyst ratings
Based on 9 analysts giving stock ratings to WST in the past 3 months
Strong buy
Buy
9
Hold
0
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for WST in the last 3 months.
Highest
Current ၃၆၆.၀၀ US$
၄၄၇.၀၀ US$ (+၂၂.၁၃%)
Average
၄၁၉.၈၈ US$ (+၁၄.၇၂%)
Lowest
၄၀၀.၀၀ US$ (+၉.၂၉%)
Analyst
Recommendation
Action
Price target
Projected
Date
Luke Sergott
Barclays
Buy
Maintained
၄၄၀.၀၀ US$
+၂၀.၂%
10/07/2026
Kallum Titchmarsh
Morgan Stanley
Buy
Upgraded
၄၀၀.၀၀ US$
+၉.၃%
09/22/2026
Unknown Analyst
UBS
Buy
Maintained
၄၁၅.၀၀ US$
+၁၃.၄%
09/09/2026
Doug Schenkel
UBS
Buy
Maintained
၄၁၅.၀၀ US$
+၁၃.၄%
09/09/2026
Joanne Wuensch
Citi
Buy
Maintained
၄၁၂.၀၀ US$
+၁၂.၆%
08/03/2026
Daniel Markowitz CFA
Evercore ISI
Buy
Maintained
၄၂၅.၀၀ US$
+၁၆.၁%
07/27/2026
Michael Ryskin
Bank of America Securities
Buy
Reiterated
၄၁၀.၀၀ US$
+၁၂%
07/24/2026
Brendan Smith
TD Cowen
Buy
Reiterated
၄၁၀.၀၀ US$
+၁၂%
07/23/2026
Matt Larew
William Blair
Buy
Maintained
-
-
07/23/2026
Curtis Moiles
Exane BNP Paribas
Buy
Initiated
၄၄၇.၀၀ US$
+၂၂.၁%
07/13/2026
Paul Knight
KeyBanc
Buy
Maintained
၃၉၀.၀၀ US$
+၆.၆%
07/02/2026
Michael Polark
Wolfe Research
Buy
Reiterated
၃၇၅.၀၀ US$
+၂.၅%
06/01/2026
Patrick B Donnelly
Citi
Buy
Maintained
၄၀၀.၀၀ US$
+၉.၃%
04/24/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
-
-
04/23/2026
Dan Leonard
UBS
Buy
Maintained
၃၄၀.၀၀ US$
-၇.၁%
02/13/2026
Justin Bowers
Deutsche Bank
Buy
Maintained
၃၁၅.၀၀ US$
-၁၃.၉%
02/13/2026
David Windley
Jefferies
Buy
Maintained
၂၉၅.၀၀ US$
-၁၉.၄%
02/10/2026
Nico Chen
DBS
Buy
Maintained
၃၂၀.၀၀ US$
-၁၂.၆%
01/28/2026
Last report
၂၀၂၆ ဇူ ၂၃
Fiscal period
Q2 2026
၂.၃၇ US$ / ၂.၀၈ US$
+၁၃.၈၆%beat
Revenue / Est. (USD)
၈၇.၂၃ ကုဋေ / ၈၄.၀၀ ကုဋေ
+၃.၈၅%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၈၀.၄၆ ကုဋေ
၈၀.၅၀ ကုဋေ
၈၄.၄၉ ကုဋေ
၈၇.၂၃ ကုဋေ
Cost of goods sold
၅၁.၀၃ ကုဋေ
၅၀.၁၁ ကုဋေ
၅၄.၈၅ ကုဋေ
၅၄.၃၁ ကုဋေ
Cost of revenue
၅၁.၀၃ ကုဋေ
၅၀.၁၁ ကုဋေ
၅၄.၈၅ ကုဋေ
၅၄.၃၁ ကုဋေ
Research and development expenses
၁.၇၁ ကုဋေ
၂.၁၈ ကုဋေ
၁.၅၈ ကုဋေ
၁.၉၇ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၁၀.၁၁ ကုဋေ
၁၀.၇၅ ကုဋေ
၉.၉၅ ကုဋေ
၁၁.၂၀ ကုဋေ
Operating expense
၁၁.၈၅ ကုဋေ
၁၂.၉၇ ကုဋေ
၁၁.၃၁ ကုဋေ
၁၃.၃၂ ကုဋေ
Total operating expenses
၆၂.၈၈ ကုဋေ
၆၃.၀၈ ကုဋေ
၆၆.၁၆ ကုဋေ
၆၇.၆၃ ကုဋေ
Operating income
၁၇.၅၈ ကုဋေ
၁၇.၄၂ ကုဋေ
၁၈.၃၃ ကုဋေ
၁၉.၆၀ ကုဋေ
Other non operating income
-၂.၀၀ သိန်း
၆.၀၀ သိန်း
-၂.၀၀ သိန်း
-၂.၀၀ သိန်း
EBT including unusual items
၁၇.၄၀ ကုဋေ
၁၆.၅၄ ကုဋေ
၁၈.၃၅ ကုဋေ
၁၈.၆၂ ကုဋေ
EBT excluding unusual items
၁၇.၉၅ ကုဋေ
၁၈.၁၂ ကုဋေ
၁၈.၈၆ ကုဋေ
၂၀.၁၂ ကုဋေ
Income tax expense
၃.၄၀ ကုဋေ
၃.၃၃ ကုဋေ
၄.၄၇ ကုဋေ
၃.၂၂ ကုဋေ
Effective tax rate
၁၉.၅၄%
၂၀.၁၃%
၂၄.၃၆%
၁၇.၂၉%
Other operating expenses
၃.၀၀ သိန်း
၄.၀၀ သိန်း
-၂.၂၀ သန်း
၁.၅၀ သန်း
Net income
၁၄.၀၀ ကုဋေ
၁၃.၂၁ ကုဋေ
၁၃.၈၈ ကုဋေ
၁၅.၄၀ ကုဋေ
Net profit margin
၁၇.၄၀%
၁၆.၄၁%
၁၆.၄၃%
၁၇.၆၅%
Earnings per share
၁.၉၆
၂.၀၄
၂.၁၃
၂.၃၇
Interest and investment income
၄.၇၀ သန်း
၅.၃၀ သန်း
၅.၁၀ သန်း
၃.၈၀ သန်း
Interest expense
-၂.၀၀ သိန်း
-
-၁.၉၀ သန်း
-၂.၆၀ သန်း
Net interest expenses
၄.၅၀ သန်း
၅.၃၀ သန်း
၃.၂၀ သန်း
၁.၂၀ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
၂၁.၈၈ ကုဋေ
၂၂.၁၂ ကုဋေ
၂၂.၈၅ ကုဋေ
၂၄.၂၂ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ